Search alternatives:
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
larger decrease » marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
-
2121
-
2122
-
2123
-
2124
Raw data.
Published 2025“…The control at 54lbs was significantly higher than at 60lbs (P<0.05). Deformation measurements were 18.53±4.90με, 16.31±4.42με, and 20.90±3.53με, with significantly lower deformation at 54lbs compared to 60lbs (P<0.05). …”
-
2125
The participants information.
Published 2025“…The control at 54lbs was significantly higher than at 60lbs (P<0.05). Deformation measurements were 18.53±4.90με, 16.31±4.42με, and 20.90±3.53με, with significantly lower deformation at 54lbs compared to 60lbs (P<0.05). …”
-
2126
-
2127
-
2128
-
2129
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
-
2130
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
-
2131
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
-
2132
-
2133
-
2134
Raw data.
Published 2025“…</p><p>Conclusion</p><p>Higher levels of remnant cholesterol and a higher RC-to-cholesterol ratio were associated with a reduced risk of vertebral fractures, particularly in women.…”
-
2135
Baseline characteristics of the subjects.
Published 2025“…</p><p>Conclusion</p><p>Higher levels of remnant cholesterol and a higher RC-to-cholesterol ratio were associated with a reduced risk of vertebral fractures, particularly in women.…”
-
2136
-
2137
-
2138
-
2139
-
2140